Effect of Smoking on Reversing Neuromuscular Block
- PMID: 27909595
- PMCID: PMC5019872
- DOI: 10.5152/TJAR.2016.97720
Effect of Smoking on Reversing Neuromuscular Block
Abstract
Objective: Rocuronium is a non-depolarising, intermediate-acting, monoquaternary amino steroid and was brought into clinical use as a potentially ideal muscle relaxant. Post-operative residual curarisation (PORC) results from the prolonged effects of non-depolarising neuromuscular blocking agents. This is a common problem and seriously affects patient safety. No recent study has investigated the effects of sugammadex on smokers, which is often used to restore neuromuscular block and avoid PORC. This study compares the severity of the effects of sugammadex used for antagonising rocuronium bromide and antagonism durations in smokers and non-smokers.
Methods: This randomised, prospective study included 40 patients scheduled for elective surgery and belonging to classes I and II based the American Society of Anesthesiologists classification, who were either smokers for at least 10 years or non-smokers. Patients underwent routine and neuromuscular monitoring. At induction, 2 mg kg-1 propofol and 1 mcg kg-1 intravenous fentanyl were applied. After the loss of eyelash reflex, 0.6 mg kg-1 intravenous rocuronium was administered. Patients were intubated at train of four (TOF) 2. Anaesthesia was continued with 50% O2+50% air and 2% sevoflurane. Rocuronium, 0.15 mg kg-1, was administered at TOF 2 during the operation. At the end of the operation, 2 mg kg-1 sugammadex was administered. The times until TOF 0.7, 0.8 and 0.9 were recorded.
Results: Intubation time was 132.8±46.4 s for smokers and 127.6±32.7 s for non-smokers. After sugammadex administration, the time to TOF 0.7 was 153.3±54.7 s in smokers and 125±67.2 s in non-smokers. The times were 178.4±58.8 and 146.6±72.6 s for TOF 0.8 and 200.8±55.8 s and 170.4±77.8 s for TOF 0.9 in smokers and non-smokers, respectively.
Conclusion: Although not statistically significant, the time to reach each TOF was longer for smokers. Larger populations and different perspectives are needed to find if sugammadex use is affected by smoking, which has negative effects on the body.
Keywords: General anaesthesia; smoking; sugammadex.
Comment in
-
Passive Smoking Also Affects Recovery from Anaesthesia.Turk J Anaesthesiol Reanim. 2017 Aug;45(4):242-243. doi: 10.5152/TJAR.2017.46656. Epub 2017 Apr 27. Turk J Anaesthesiol Reanim. 2017. PMID: 28868176 Free PMC article. No abstract available.
-
The Negative Influence of Cigarette Smoke on Passive Smokers-Deteriorated Pulmonary Function Tests and Increased Urine Cotinine Levels.Turk J Anaesthesiol Reanim. 2019 Jun;47(3):242-243. doi: 10.5152/TJAR.2019.98415. Epub 2019 Feb 19. Turk J Anaesthesiol Reanim. 2019. PMID: 31183473 Free PMC article. No abstract available.
References
-
- Özcengiz D. Neuromuscular blockers. Türkiye Klinikleri J Anest Reanim. 2005;3:116–30.
-
- Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111:110–9. - PubMed
-
- Kim KS, Lew SH, Cho HY, Cheong MA. Residual paralysis induced bye it her vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg. 2002;95:1656–60. http://dx.doi.org/10.1097/00000539-200212000-00033. - DOI - PubMed
-
- Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth. 2008;100:622–30. http://dx.doi.org/10.1093/bja/aen037. - DOI - PubMed
-
- Sacan O, White PF, Tufanogulları B, Klein K. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth Analg. 2007;104:569–74. http://dx.doi.org/10.1213/01.ane.0000248224.42707.48. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources